Improved Synthesis of (–)-Agelastatin A

Abstract

Optimization of key steps in the synthesis of the architecturally unique tetracyclic antitumor alkaloid (–)-agelastatin A (1) improved the overall yield of the 11-step process (eight operations) from 9% to 23%. Changing the solvent and using a more efficient N-benzyl deprotecting-group procedure enhanced the yields of the C-ring and D-ring intermediates, (–)-4 and (–)-7, respectively. Bromination of (–)-7 with 1,3-dibromo-5,5-dimethylhydantoin, rather than N-bromosuccinimide (NBS), increased the yield of (–)-1 from 69% to more than 94% yield.